Abbott Laboratories (ABT) |
|
|
|
Abbott Laboratories Income Statement Quarterly
ABT
Select the Financial Report: |
Period: |
Fiscal Year: |
|
|
|
INCOME STATEMENT (Quarterly GAAP In millions $) |
(Dec 31 2018) IV. Quarter |
(Sep 30 2018) III. Quarter |
(Jun 30 2018) II. Quarter |
(Mar 31 2018) I. Quarter |
(Dec 31 2017) IV. Quarter |
Revenue From Contract With Customer Excluding Assessed Tax |
|
- |
7,767.00 |
7,390.00 |
|
Revenue From Contract With Customer Excluding Assessed Tax |
|
7,656.00 |
- |
- |
|
Total Revenue |
7,765.00 |
7,656.00 |
7,767.00 |
7,390.00 |
7,589.00 |
Cost of Goods and Services Sold |
3,191.00 |
3,166.00 |
3,282.00 |
3,067.00 |
3,263.00 |
Gross
Profit |
4,574.00 |
4,490.00 |
4,485.00 |
4,323.00 |
3,766.00 |
Selling, Administration, Marketing |
2,359.00 |
2,377.00 |
2,466.00 |
2,542.00 |
2,462.00 |
Depriciation & Amortization |
488.00 |
544.00 |
562.00 |
584.00 |
560.00 |
Research and Development Expense |
562.00 |
574.00 |
575.00 |
589.00 |
613.00 |
Restructuring charges |
- |
- |
- |
- |
- |
Other exp. /-income |
- |
- |
- |
- |
- |
Special Items |
- |
- |
- |
- |
- |
Total operating costs including COS |
6,600.00 |
6,661.00 |
6,885.00 |
6,782.00 |
6,898.00 |
Operating income/-loss
|
1,165.00 |
995.00 |
882.00 |
608.00 |
691.00 |
Other Deductions / - Income |
Interest expense |
186.00 |
203.00 |
210.00 |
227.00 |
674.00 |
Interest income |
- |
- |
- |
- |
- |
Net interest expense/-income |
186.00 |
203.00 |
210.00 |
227.00 |
246.00 |
Extinguishment of Debt |
248.00 |
67.00 |
- |
14.00 |
- |
Investment Income, Interest |
- |
- |
- |
- |
-97.00 |
Foreign Currency Transaction Gain (Loss), before Tax |
30.00 |
11.00 |
-6.00 |
-3.00 |
-24.00 |
Sale of Assets |
- |
- |
- |
- |
- |
Financing Loss/ -Income |
- |
- |
- |
- |
- |
Other loss/ -income |
-246.00 |
-4.00 |
-99.00 |
-61.00 |
-82.00 |
Total costs & expenses |
6,818.00 |
6,938.00 |
6,990.00 |
6,959.00 |
6,898.00 |
Income /-loss before income taxes |
947.00 |
718.00 |
777.00 |
431.00 |
574.00 |
Income taxes expenses/-benefit |
292.00 |
166.00 |
59.00 |
22.00 |
1,438.00 |
Income after income taxes |
655.00 |
552.00 |
718.00 |
409.00 |
-864.00 |
Net income/-loss
of other equity |
-34.00 |
- |
- |
- |
-36.00 |
Income/-loss
from cont. Ops. |
621.00 |
552.00 |
718.00 |
409.00 |
-900.00 |
Accounting change |
- |
- |
- |
- |
- |
Discontinued operations |
33.00 |
11.00 |
15.00 |
9.00 |
72.00 |
Extraordinary items |
- |
- |
- |
- |
- |
Net Income/-loss |
654.00 |
563.00 |
733.00 |
418.00 |
-828.00 |
Noncontrolling interests |
- |
- |
- |
- |
- |
Prefered dividends |
- |
- |
- |
- |
- |
Other |
- |
- |
- |
- |
- |
Income/-loss to shareholder |
654.00 |
563.00 |
733.00 |
418.00 |
-828.00 |
EBIT |
1,133.00 |
921.00 |
987.00 |
658.00 |
820.00 |
EBITD |
1,408.00 |
1,190.00 |
1,275.00 |
926.00 |
1,103.00 |
EBITDA |
1,896.00 |
1,734.00 |
1,837.00 |
1,510.00 |
1,668.00 |
Per
Share (GAAP Quarterly, in $) |
(Dec 31 2018) IV. Quarter |
(Sep 30 2018) III. Quarter |
(Jun 30 2018) II. Quarter |
(Mar 31 2018) I. Quarter |
(Dec 31 2017) IV. Quarter |
Basic EPS (excl. extra
items) |
0.37 |
0.31 |
0.41 |
0.23 |
-0.50 |
Extraordinary items |
0.00 |
0.01 |
0.01 |
0.01 |
0.00 |
Basic Net EPS |
0.37 |
0.32 |
0.42 |
0.24 |
-0.48 |
Basic shares outstanding (Mill.
of Units) |
1,761.17 |
1,759.59 |
1,757.84 |
1,753.41 |
1,748.36 |
EPS other shares |
- |
- |
- |
- |
- |
Diluted Net EPS |
0.37 |
0.32 |
0.41 |
0.23 |
-0.48 |
Diluted average shares (Mill.
of Units) |
1,774.09 |
1,771.68 |
1,768.95 |
1,765.28 |
1,757.77 |
Dividend per share |
0.279 |
0.28 |
0.28 |
0.28 |
0.264 |
|
|